Browsing by Author "Alamo, M."
Now showing 1 - 3 of 3
Results Per Page
Sort Options
- ItemOpen label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery(2009) Tarnoff, M.; Rodriguez, L.; Escalona, A.; Ramos, A.; Neto, M.; Alamo, M.; Reyes, E.; Pimentel, F.; Ibanez, L.The duodenal-jejunal bypass sleeve (DJBS) has been shown to achieve a completely endoscopic duodenal exclusion without the need for stapling. This report is the first randomized controlled trial for weight loss.
- ItemThe exocyst controls lysosome secretion and antigen extraction at the immune synapse of B cells(2019) Sáez, J. J.; Díaz Muñoz, Jheimmy Maríana; Ibáñez, J.; Bozo, J. P.| Reyes, F. C.; Alamo, M.; Gobert, F. X.; Obino, D.; Bono, M. R.; Lennon Dumenil, A. M.; Yeaman, C.; Yuseff Sepúlveda, María Isabel
- ItemTumour necrosis factor (TNF)α-308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis(2006) Cuchacovich, M.; Soto, L.; Edwardes, M.; Gutierrez, M.; Llanos, C.; Pacheco, D.; Sabugo, F.; Alamo, M.; Fuentealba, C.; Villanueva, L.; Gatica, H.; Schiattino, I.; Salazar, L.; Catalan, D.; Valenzuela, O.Objective: To investigate the influence of -308 tumour necrosis factor-alpha (TNF alpha) promoter polymorphism and circulating TNF alpha levels in the clinical response to adalimumab treatment in patients with rheumatoid arthritis (RA).